12 Patents
- US126066052026Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
AKSTON BIOSCIENCES CORPORATION
0 cites - US124545652025PD-L1 Analog Fusion Proteins for Antigen Specific Immunotherapy and Methods of Use
AKSTON BIOSCIENCES CORPORATION
0 cites - US123433932025Antigen Specific Immunotherapy for COVID-19 Fusion Proteins and Methods of Use
Vakston, Inc.
0 cites - 0 cites
- 0 cites
- US119199352024Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites - US118144182023Ultra-long Acting Insulin-fc Fusion Protein and Methods of Use
Akston Biosciences Corporation
0 cites - US117731512023Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites - US117075172023Antigen Specific Immunotherapy for COVID-19 Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites - US116739342023Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites - US116676892023Insulin-fc Fusion Proteins and Methods of Use to Treat Cancer
Akston Biosciences Corporation
0 cites - US115550582023Cells Engineered to Express Ultra-long Acting Insulin-fc Fusion Proteins
Akston Biosciences Corporation
0 cites